Skip to main content

and
  1. No Access

    Article

    The next generation of therapeutics for chronic kidney disease

  2. Approximately 20 million people in the United States are currently affected by CKD, with half a million of these presenting with the most severe form: end-stag...

  3. Matthew D. Breyer, Katalin Susztak in Nature Reviews Drug Discovery (2016)

  4. No Access

    Article

    Increased dietary sodium induces COX2 expression by activating NFκB in renal medullary interstitial cells

    High salt diet induces renal medullary cyclooxygenase 2 (COX2) expression. Selective blockade of renal medullary COX2 activity in rats causes salt-sensitive hypertension, suggesting a role for renal medullary ...

    Wenjuan He, Min Zhang, Min Zhao in Pflügers Archiv - European Journal of Phys… (2014)

  5. Article

    Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1

    To examine the contribution of vascular membrane-associated prostaglandin E2 synthase-1 (mPGES-1) to acute blood pressure homeostasis.

    Dong-juan Zhang, Li-hong Chen, Ya-hua Zhang, Guang-rui Yang in Acta Pharmacologica Sinica (2010)

  6. No Access

    Protocol

    Measurement of Glomerular Filtration Rate in Conscious Mice

    Glomerular filtration rate (GFR) is an important index of renal function and routinely used in patient care and basic research to evaluate progression of renal diseases or test the efficacy of novel therapeuti...

    Zhonghua Qi, Matthew D. Breyer in Kidney Research (2009)

  7. No Access

    Reference Work Entry In depth

    Prostanoids

    Richard M. Breyer, Aaron N. Hata in Encyclopedia of Molecular Pharmacology (2008)

  8. No Access

    Article

    Examining diabetic nephropathy through the lens of mouse genetics

    Although diabetic nephropathy occurs in only a minority of patients with diabetes, it is the major cause of end-stage renal disease in the United States. Hyperglycemia and hypertension are important factors pr...

    Matthew D. Breyer, Elena Tchekneva, Zhonghua Qi in Current Diabetes Reports (2007)

  9. No Access

    Article

    Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption

    Thiazolidinediones (TZDs) are widely used to treat type 2 diabetes mellitus; however, their use is complicated by systemic fluid retention. Along the nephron, the pharmacological target of TZDs, peroxisome pro...

    YouFei Guan, Chuanming Hao, Dae Ryong Cha, Reena Rao, Wendell Lu in Nature Medicine (2005)

  10. Article

    Open Access

    Cloning and expression of the rabbit prostaglandin EP2 receptor

    Prostaglandin E2 (PGE2) has multiple physiologic roles mediated by G protein coupled receptors designated E-prostanoid, or "EP" receptors. Evidence supports an important role for the EP2 receptor in regulating fe...

    Youfei Guan, Brett A Stillman, Yahua Zhang, André Schneider in BMC Pharmacology (2002)

  11. No Access

    Chapter

    Targeted gene disruption of the prostaglandin e2 ep2 receptor

    Prostaglandins comprise a diverse family of autacoids derived from cyclooxygenase (COX) metabolism of arachidonic acid to PGG/H2, leading to the generation of five principal bio-active prostaglandin (PG) metab...

    Richard M. Breyer, Christopher R. J. Kennedy in Eicosanoids and Other Bioactive Lipids in … (2002)

  12. No Access

    Article

    Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor

    Prostaglandins (PGs) are ubiquitous lipid mediators derived from cyclooxygenase metabolism of arachidonic acid that exert a broad range of physiologic activities, including modulation of inflammation, ovulation1,

    Christopher R.J. Kennedy, Yahua Zhang, Suzanne Brandon, Youfei Guan in Nature Medicine (1999)

  13. No Access

    Chapter

    Structure and Localization of the Rabbit Prostaglandin EP3 Receptor

    Prostaglandin E2 (PGE2) is a potent modulator of a wide variety of physiological responses including inflammation (1), gastric acid secretion (2), vascular tone (3), lipolysis (4) and water and ion transport (5)....

    Richard M. Breyer, Ronald B. Emeson in Eicosanoids and Other Bioactive Lipids in … (1997)